Compare M&T Bank Corporation (MTB) vs Nuvalent Inc (NUVL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
M&T Bank Corporation vs Nuvalent Inc — how do they compare? M&T Bank Corporation trades at $248.99 (market cap $36.15B), while Nuvalent Inc trades at $123.96 (market cap $9.81B). The key difference: M&T Bank Corporation is far larger — about 3.7× Nuvalent Inc's market cap, and M&T Bank Corporation pays a 2.41% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| MTB | NUVL | |
|---|---|---|
Market Cap | $36.15B | $9.81B |
Sector | Financials | Technology |
52-Week High | $254.04 | $123.96 |
52-Week Low | $178.63 | $72.16 |
Dividend Yield | 2.41% | — |
Enterprise Value | — | $8.52B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
M&T Bank (MTB) trades at $248.66, down 0.23% on the day, with a bullish technical outlook supported by moving averages and strong support near $248. The stock shows solid fundamentals, including a P/E of 13.2, net income margin of 30.85%, and three consecutive quarterly EPS beats, most recently with Q2 2026 actual EPS of $5.35 versus $4.66 expected. Revenue growth is steady, reaching $9.63 billion in 2025, and the company maintains a dividend, with H1-26 paying $1.50 per share.
The outlook for MTB is positive, driven by earnings momentum and analyst consensus, though risks include elevated debt levels and potential macroeconomic pressures on net interest income. With a consensus price target of $253.68 and 62.5% of analysts rating it Hold, the stock offers moderate upside with a focus on execution and loan growth sustainability.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About M&T Bank Corporation
M&T Bank is one of the largest regional banks in the United States, with branches in New York, Pennsylvania, West Virginia, Virginia, Maryland, Delaware, and New Jersey. The bank was founded to serve manufacturing and trading businesses around the Erie Canal and is primarily focused on commercial real estate and commercial-related lending, with some retail operations also present.
Read more on MTB →About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →
